FRAXA's mission is to find specific treatments and ultimately a cure for Fragile X syndrome. We aim to bring practical treatment into current medical practice as quickly as possible; we prioritize projects that have a clear practical application and the results of which will be shared in a timely fashion. FRAXA awards Clinical Trial Grants. These grants are strictly for clinical research with human subjects who have Fragile X. This grant is flexible in amount, structure, and duration, but may be subject to some negotiation. Emphasis will be placed on clinical trials of potentially disease-modifying agents which have been...